Get the Stockscreener App
0.85
13.74%
0.1027
Applied Therapeutics Inc stock is traded at $0.85, with a volume of 2.75M.
It is up +13.74% in the last 24 hours and down -20.56% over the past month.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.7473
Open:
$0.76
24h Volume:
2.75M
Relative Volume:
0.58
Market Cap:
$122.41M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
-0.6296
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
-26.09%
1M Performance:
-20.56%
6M Performance:
+102.38%
1Y Performance:
-91.27%
1-Day Range:
$0.7513
$0.85
1-Week Range:
$0.7455
$1.15
52-Week Range:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Name
Applied Therapeutics Inc
Sector
Industry
Phone
212-220-9226
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Compare APLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.85 | 107.62M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-02-24 | Downgrade | UBS | Buy → Neutral |
| Nov-29-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-31-24 | Initiated | William Blair | Outperform |
| Mar-26-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-22-24 | Initiated | Leerink Partners | Outperform |
| Jan-04-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Aug-27-21 | Downgrade | Goldman | Neutral → Sell |
| Jun-25-21 | Resumed | Goldman | Neutral |
| Oct-08-20 | Initiated | Truist | Buy |
| Apr-22-20 | Initiated | Goldman | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jun-10-19 | Initiated | Citigroup | Buy |
| Jun-10-19 | Initiated | Cowen | Outperform |
| Jun-10-19 | Initiated | Robert W. Baird | Outperform |
View All
Applied Therapeutics Inc Stock (APLT) Latest News
How Applied Therapeutics Inc. (2UV) stock moves in volatile trading sessionsJuly 2025 Action & AI Enhanced Trading Signals - newser.com
Can a trend reversal in Applied Therapeutics Inc. lead to recoveryMarket Performance Recap & Stock Portfolio Risk Management - newser.com
Custom watchlist performance reports with Applied Therapeutics Inc.Entry Point & Precise Buy Zone Identification - newser.com
Will Applied Therapeutics Inc. stock recover faster than peersMarket Activity Summary & Real-Time Volume Analysis Alerts - newser.com
How geopolitical tensions affect Applied Therapeutics Inc. stockTrade Analysis Summary & Short-Term Trading Alerts - newser.com
Developing predictive dashboards with Applied Therapeutics Inc. dataJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
Can Applied Therapeutics Inc. (2UV) stock ride next bull market cycle2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
Statistical indicators supporting Applied Therapeutics Inc.’s strength2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com
Can Applied Therapeutics Inc. (2UV) stock surprise markets with earnings2025 Big Picture & Weekly High Return Opportunities - newser.com
Is Applied Therapeutics Inc. (2UV) stock among top earnings playsMarket Performance Report & Daily Market Momentum Tracking - newser.com
Analyzing Applied Therapeutics Inc. with multi timeframe charts2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Can Applied Therapeutics Inc. (2UV) stock double in coming years2025 Bull vs Bear & Growth-Oriented Investment Plans - newser.com
Is Applied Therapeutics Inc. stock a defensive play in 2025July 2025 Final Week & AI Driven Price Predictions - fcp.pa.gov.br
Volume spikes in Applied Therapeutics Inc. stock – what they meanJuly 2025 Trade Ideas & Safe Capital Growth Stock Tips - newser.com
What makes Applied Therapeutics Inc. stock attractive to growth fundsQuarterly Profit Summary & Low Risk Entry Point Tips - newser.com
Will Applied Therapeutics Inc. stock benefit from AI adoption2025 Analyst Calls & Breakout Confirmation Alerts - fcp.pa.gov.br
Will Applied Therapeutics Inc. stock reach Wall Street targets2025 Market Sentiment & Stepwise Trade Signal Guides - fcp.pa.gov.br
Does Applied Therapeutics Inc. show high probability of reboundProfit Target & Advanced Swing Trade Entry Alerts - newser.com
Why Applied Therapeutics Inc. (2UV) stock is a must watch ticker - newser.com
What data driven models say about Applied Therapeutics Inc.’s futureWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com
Real time alert setup for Applied Therapeutics Inc. performance2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-11-05 23:48:27 - newser.com
News impact scoring models applied to Applied Therapeutics Inc.Buy Signal & Reliable Volume Spike Trade Alerts - newser.com
Applied Therapeutics Inc. (NASDAQ:APLT) Given Average Rating of "Hold" by Brokerages - MarketBeat
Applied Therapeutics Inc. stock daily chart insightsMarket Trend Report & Fast Entry Momentum Alerts - newser.com
What does recent volatility data suggest for Applied Therapeutics Inc.July 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - newser.com
Is Applied Therapeutics Inc. stock a good choice for value investors2025 Technical Overview & Reliable Volume Spike Alerts - newser.com
Applied Therapeutics Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Applied Therapeutics Inc Stock (APLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):